lilly obesity pill - Search News

News

Eli Lilly weight loss pill shows promise

Eli Lilly closer to breakthrough weight loss drug; shares tumble as some question results

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body weight.

Eli Lilly’s Obesity Pill Shows Promising Weight Loss in New Results

In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 percent of their body weight.

CNBC on MSN · 19h

Eli Lilly's obesity pill led to around 12% weight loss in closely watched late-stage trial; shares drop

Eli Lilly's pill, orforglipron, is one step closer to becoming the first new, needle-free alternative in the booming market for weight loss and diabetes drugs.

BioPharma Dive13h

Lilly shares fall as obesity pill misses expectations in key trial

While orforglipron succeeded in a Phase 3 trial, its weight loss effects were more modest than investors and analysts ...

11hon MSN

Eli Lilly Shares Plummet 14% Toward Worst Day In 25 Years—Here’s Why It’s Down

Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results